{
    "3 20 2025": {
        "importantArticles": [
            {
                "headline": "Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder",
                "publication_date": "2025-03-20T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.2023",
                "source": "GuruFocus.com",
                "ticker": "HLN",
                "title": "Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant",
                "url": "https://finance.yahoo.com/news/pfizer-sells-final-haleon-shares-133919948.html"
            },
            {
                "headline": "Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.",
                "publication_date": "2025-03-20T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Zacks",
                "ticker": "HLN",
                "title": "Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B",
                "url": "https://finance.yahoo.com/news/pfizer-sells-remaining-7-3-124500233.html"
            },
            {
                "headline": "The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.",
                "publication_date": "2025-03-20T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Pharmaceutical Technology",
                "ticker": "HLN",
                "title": "Pfizer sells 7.3% stake in Haleon for $3.3bn",
                "url": "https://finance.yahoo.com/news/pfizer-sells-7-3-stake-121824305.html"
            },
            {
                "headline": "The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.",
                "publication_date": "2025-03-20T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Pharmaceutical Technology",
                "ticker": "HLN",
                "title": "Pfizer sells 7.3% stake in Haleon for $3.3bn",
                "url": "https://finance.yahoo.com/news/pfizer-sells-7-3-stake-121824305.html"
            },
            {
                "headline": "Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.",
                "publication_date": "2025-03-20T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "Zacks",
                "ticker": "HLN",
                "title": "Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B",
                "url": "https://finance.yahoo.com/news/pfizer-sells-remaining-7-3-124500233.html"
            },
            {
                "headline": "Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder",
                "publication_date": "2025-03-20T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.2023",
                "source": "GuruFocus.com",
                "ticker": "HLN",
                "title": "Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant",
                "url": "https://finance.yahoo.com/news/pfizer-sells-final-haleon-shares-133919948.html"
            }
        ],
        "avgScore": 0.06743333333333333
    },
    "3 19 2025": {
        "importantArticles": [
            {
                "headline": "Under the deal, Sensodyne maker Haleon has agreed to buy back 44 million shares from Pfizer, currently its largest shareholder, with 618 million shares being sold to institutional investors.  The total sale represents 7.3% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019.",
                "publication_date": "2025-03-19T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.8271",
                "source": "Reuters",
                "ticker": "HLN",
                "title": "Pfizer sells entire Haleon stake for $3.24 billion",
                "url": "https://finance.yahoo.com/news/pfizer-sells-entire-haleon-stake-072643649.html"
            },
            {
                "headline": "Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon, created in a merger of GSK and Pfizer's consumer healthcare businesses in 2019, and spun off in 2022.  Under the deal, the Sensodyne maker has agreed to buy back shares worth $220 million from Pfizer, currently its largest shareholder.",
                "publication_date": "2025-03-19T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.8126",
                "source": "Reuters",
                "ticker": "HLN",
                "title": "Pfizer to sell entire Haleon stake",
                "url": "https://finance.yahoo.com/news/pfizer-sell-entire-haleon-stake-165448231.html"
            },
            {
                "headline": "Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating",
                "publication_date": "2025-03-19T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.7184",
                "source": "Investor's Business Daily",
                "ticker": "HLN",
                "title": "Teva Pharmaceutical Stock Scores RS Rating Upgrade",
                "url": "https://finance.yahoo.com/m/04de21f0-07dc-3e0d-b449-f61687506067/teva-pharmaceutical-stock.html"
            },
            {
                "headline": "Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.",
                "publication_date": "2025-03-19T00:00:00.000Z",
                "sentiment": "Neutral",
                "sentimentScore": "0.0",
                "source": "PA Media: Money",
                "ticker": "HLN",
                "title": "Pfizer offloads final shares in Sensodyne maker Haleon",
                "url": "https://finance.yahoo.com/news/pfizer-offloads-final-shares-sensodyne-091842639.html"
            },
            {
                "headline": "Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating",
                "publication_date": "2025-03-19T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.7184",
                "source": "Investor's Business Daily",
                "ticker": "HLN",
                "title": "Teva Pharmaceutical Stock Scores RS Rating Upgrade",
                "url": "https://finance.yahoo.com/m/04de21f0-07dc-3e0d-b449-f61687506067/teva-pharmaceutical-stock.html"
            },
            {
                "headline": "Pfizer will sell about 662 million ordinary shares, or 7.3%, of Haleon, created in a merger of GSK and Pfizer's consumer healthcare businesses in 2019, and spun off in 2022.  Under the deal, the Sensodyne maker has agreed to buy back shares worth $220 million from Pfizer, currently its largest shareholder.",
                "publication_date": "2025-03-19T00:00:00.000Z",
                "sentiment": "Positive",
                "sentimentScore": "0.8126",
                "source": "Reuters",
                "ticker": "HLN",
                "title": "Pfizer to sell entire Haleon stake",
                "url": "https://finance.yahoo.com/news/pfizer-sell-entire-haleon-stake-165448231.html"
            }
        ],
        "avgScore": 0.589525
    },
    "coef": 0.9999999999999999,
    "avgCoef": -0.05354411772848244,
    "similar": {
        "NVDA": 0.9999999999999999,
        "BTG": 0.9999999999999999,
        "BAC": 0.9999999999999999,
        "AGNC": 0.9999999999999999
    }
}